HCPCS J2916: Injection, Sodium Ferric Gluconate Complex in Sucrose Injection, 12.5 mg

Learn more about the documentation and billing requirements to properly use and bill for HCPCS code J2916.

## **What is HCPCS code J2916?** J2916 is the HCPCS Level II code for Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg, commonly marketed under the brand name Ferrlecit. As a J-code, it identifies the drug product itself for billing and reimbursement, with each billed unit representing the iron agent. The primary purpose of this medication is to treat iron deficiency anemia by providing intravenous (IV) iron replacement, which is administered directly into the bloodstream for rapid replenishment of iron stores. This route is typically chosen for patients who cannot tolerate or absorb oral iron supplements or who require immediate iron repletion. The most common use is in patients with chronic kidney disease (CKD), particularly those on hemodialysis who are also receiving erythropoietin-stimulating agents (ESAs) to manage their anemia. It can also be used for patients with inflammatory bowel disease and those who have had gastric bypass surgery, or for cases of chemotherapy-induced anemia and disorders of iron metabolism.

## **Documentation requirements** Accurate and complete medical record documentation is essential for proper billing and reimbursement for the Ferrlecit J Code or J2916. Key documentation should include: ### **Medical necessity** - The patient's diagnosis (e.g., iron deficiency anemia due to CKD, identified by the appropriate ICD-10 code). - Documentation of the medical reason for administering IV iron, such as failure to respond to or intolerance of oral iron, or the patient's specific iron status and clinical condition (e.g., being on chronic hemodialysis and receiving epoetin therapy). - Relevant laboratory results (e.g., hemoglobin, hematocrit, serum ferritin, and transferrin saturation (TSAT) levels) that demonstrate iron deficiency, supporting the need for the injection. ### **Drug administration details** - The full name of the drug, sodium ferric gluconate complex in sucrose, and the total dosage administered in milligrams (mg). - Route of administration - Date and time of the injection/infusion. - Administering personnel (e.g., RN, LPN). - Documentation of patient monitoring during and after the infusion for adverse reactions. - If a portion of a single-dose vial is discarded, the amount wasted must be documented in the medical record and may require the use of the JW or JZ modifier on the claim (see Billing Guidelines).

## **Billing requirements** To accurately bill for HCPCS code J2916, one must consider the following guidelines/requirements ### **Units of service** The billed units for J2916 must reflect the total milligrams given. For example, if a patient receives 125 mg, you would bill 10 units. ### **Administration codes** The administration code is billed once per encounter for the primary infusion service. ### **Discarded drug (wastage) modifiers** - **JW Modifier**: Used on a separate line item with the discarded amount (units) from a single-dose container. - **JZ Modifier**: Used on the line item for the administered drug when there is zero drug amount discarded. ### **Payer-specific policies** Coverage, coding, and payment for J2916 are highly dependent on the individual payer (Medicare, Medicaid, or private insurance). Always confirm the specific diagnosis codes and billing rules with the payer's most current policy for intravenous iron therapy.

## **Other relevant codes** - **J0612**: Injection, calcium gluconate, not otherwise specified, 10 mg - **J3480**: Injection, potassium chloride, per 2 mEq - **J3475**: Injection, magnesium sulfate, per 500 mg - **J1756**: Injection, iron sucrose, 1 mg - **J1750**: Injection, iron dextran, 50 mg - **D63.0**: Anemia in neoplastic disease - **D63.1**: Anemia in chronic kidney disease - **D50.9**: Iron deficiency anemia, unspecified. - **96365**: Intravenous infusion, initial, up to 1 hour - **96366**: IV infusion, each additional hour

Frequently asked questions

No. J2916 covers only the cost of the drug product itself (sodium ferric gluconate complex in sucrose).

The billed units are calculated by dividing the total dose administered by the code's unit dosage.

For Medicare and many other payers, the use of the JW (drug wastage) or JZ (zero wastage) modifiers is often required for drugs supplied in single-dose containers, like Ferrlecit. Providers must check the specific payer's guidelines and apply the appropriate modifier to attest to the amount administered and/or the amount discarded.